Thymalin
Thymulin, Thymic Factor, Serum Thymic Factor, Facteur Thymique Serique
A synthetic thymic nonapeptide that modulates immune function by promoting T-cell differentiation and enhancing overall immunity.
Completed
NA
NCT01233921
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
Martin, Paul
INTERVENTIONAL
Updated Dec 15, 2025
Enrolling By Invitation
PHASE1, PHASE2
NCT06851767
Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy
National Institute of Allergy and Infectious Diseases (NIAID)
INTERVENTIONAL
Updated Dec 15, 2025
Not Yet Recruiting
NCT07133685
Evaluation of Serum IL-7 as a Biomarker in Breast Cancer
Assiut University
OBSERVATIONAL
Updated Dec 15, 2025
Terminated
PHASE1, PHASE2
NCT01100944
A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT01229579
Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan
Aga Khan University
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NCT05399745
BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease
Rigshospitalet, Denmark
OBSERVATIONAL
Updated Dec 15, 2025
Recruiting
PHASE2
NCT02015013
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
National Institute of Allergy and Infectious Diseases (NIAID)
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE1
NCT04007029
Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
Jonsson Comprehensive Cancer Center
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1, PHASE2
NCT00374699
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
Samsung Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00376935
Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults
National Institute of Allergy and Infectious Diseases (NIAID)
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT06626971
The Use of ARA290 for the Treatment of Diabetic Macular Oedema
Belfast Health and Social Care Trust
INTERVENTIONAL
Updated Dec 15, 2025
Withdrawn
PHASE2
NCT01610544
18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE1, PHASE2
NCT04224558
Stem Cell Transplantation in Crohn's Disease
Cedars-Sinai Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
NCT04520165
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
University of Liege
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT01306045
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00965250
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
EARLY PHASE1
NCT01760226
Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies
Baylor College of Medicine
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NCT06669949
Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
University of California, San Francisco
OBSERVATIONAL
Updated Dec 15, 2025
Completed
NA
NCT04986384
Effect of a Topical Spray on Itch Relief in Moderate-to-severe Childhood Eczema
Prof. HON Kam Lun Ellis
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT03449758
Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis
Sanofi
INTERVENTIONAL
Updated Dec 15, 2025